U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07268313) titled 'Complete Remission After Treatment With Biologics for Nasal Polyps' on Sept. 02.

Brief Summary: In this RCT the investigators randomize patients who are treated with biologic treatment (Nucala or Dupixent) due to nasal polyps and have controlled disease within the last year to either stop treatment og continue as a control group.

Study Start Date: April 03

Study Type: INTERVENTIONAL

Condition: Nasal Polyps

Intervention: DRUG: DUPIXENT(R)

Continue Dupixent

DRUG: NUCALA(R)

"Continue Nucala

OTHER: Dupi discontinuation

Stop taking Dupixent at baseline; no substitute is given

OTHER: Mepo discontinuation

Stop taking Nucala at ...